Home
Maitreya Medicare Ltd Share Price History
Maitreya Medicare Ltd
NSE : 13 Aug, 2025
261.8-5.7 (-2.1%)
Prev Close
267.5
Open Price
259.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
800
Today's High / Low
266.0 / 259.5
52 WK High / Low
400.0 / 185.0
Market Price of Maitreya Medicare Ltd
1M
1Y
3Y
5Y
Monitoring Maitreya Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2021 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 3995.41 |
| YoY Gr. | - |
| Net Profit (Cr.) | 4 |
| BVPS | 3862.16 |
Key Financial Parameters
| Parameter | 2021 |
|---|---|
| Return on Capital Emp. % | 36.13 |
| Op. Profit Mgn % | 13.57 |
| Net Profit Mgn % | 7.49 |
| Debt to Equity % | 1.03 |
Latest Shareholding
Promoters Holdings Over Time
About Maitreya Medicare Ltd
- Maitreya Medicare Ltd was originally incorporated as Maitreya Medicare Private Limited' at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC).
- Thereafter, name of the Company was changed from Maitreya Medicare Private Limited' to Maitreya Medicare Limited' and a fresh Certificate of Incorporation consequent to change of name was issued by the RoC on March 30, 2023.
- The Company is engaged into providing healthcare services and products. The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry.
- Maitreya Medicare Limited is a 125 bedded, Multi Superspeciality hospital incorporated in 2019 based out in Surat City, Gujarat, providing ultimate secondary and tertiary healthcare services at affordable charges.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
